about
NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population.A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS).Effect of microbubble contrast on intracranial blood flow velocity assessed by transcranial Doppler.Risk factors and their impact on carotid intima-media thickness in young and middle-aged ischemic stroke patients and controls: the Norwegian Stroke in the Young Study.Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke StudyThe Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study.Early vascular aging in young and middle-aged ischemic stroke patients: the Norwegian Stroke in the Young Study.Comparison between Ischemic Stroke Patients <50 Years and ≥50 Years Admitted to a Single Centre: The Bergen Stroke Study.Decline of arterial cerebral infarction among young women: the Bergen Stroke StudyThe Norwegian Stroke in the Young Study (NOR-SYS): rationale and designStroke patients' knowledge about cardiovascular family history - the Norwegian Stroke in the Young Study (NOR-SYS).Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke.Low body temperature associated with severe ischemic stroke within 6 hours of onset: The Bergen NORSTROKE Study.Comparing withdrawal and non-withdrawal of life-sustaining treatment among patients who died from strokeA Family History of Stroke Is Associated with Increased Intima-Media Thickness in Young Ischemic Stroke - The Norwegian Stroke in the Young Study (NOR-SYS).Persistent atrial fibrillation is associated with worse prognosis than paroxysmal atrial fibrillation in acute cerebral infarctionPersistent middle cerebral artery occlusion associated with lower body temperature on admission.Early ischemic CT changes before thrombolysis: The influence of age and diabetes mellitusU-curve relation between cholesterol and prior ischemic stroke.A stress-related explanation to the increased blood pressure and its course following ischemic stroke.Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?Hospital Readmission after Intracerebral Hemorrhage.The effect of physiologic derangement in patients with stroke treated with thrombolysis.Prevalence and covariates of masked hypertension in ischemic stroke survivors: the Norwegian Stroke in the Young Study.Atherosclerosis in Trial of Org 10172 in Acute Stroke Treatment Subtypes among Young and Middle-Aged Stroke Patients: The Norwegian Stroke in the Young Study.Does a history of migraine affect the rate of thrombolysis in young stroke patients?Carotid intima-media thickness--a potential predictor for rupture risk of intracranial aneurysms.Fatigue among stroke patients on long-term follow-up. The Bergen Stroke Study.Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE Study.Prevalence of intracranial stenosis in a Norwegian ischemic stroke population.C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients.Preadmission use of warfarin improves short-term outcome in patients with acute cerebral infarction. The Bergen Stroke Study.Clinical Importance of Temporal Bone Features for the Efficacy of Contrast-Enhanced Sonothrombolysis: a Retrospective Analysis of the NOR-SASS Trial.Time patterns in multiple acute cerebral infarcts.Serum albumin in ischemic stroke patients: the higher the better. The Bergen Stroke Study.High proportion of lacunar strokes at night: the Bergen stroke study.Arterial events after ischemic stroke at a young age: a cross-sectional long-term follow-up of patients and controls in western Norway.Post-stroke pain on long-term follow-up: the Bergen stroke study.
P50
Q30363884-DFED9BB1-BB2E-4E41-BB8B-22863F373A28Q30407045-781B989A-1885-499E-9160-E348BB9A62E0Q30431973-AD4DE535-34E4-4F46-A980-76D4450E6BB8Q31154671-5CEC1FE6-A35C-4EB5-9967-297C532FACC7Q33436029-79C25856-A2CF-499B-B566-FD76EFC5B985Q33494750-01F0B474-7340-41B1-8605-C9F0B716FA3DQ33645859-FFF8C5F3-2D1C-4414-9641-DA1C9FE84065Q34029316-67A9783D-D77C-48EB-94BE-4275F3B92075Q34535521-38DD77E7-58BC-408B-A83D-4CBD73392B06Q34557454-9971A1B6-06A2-4C1B-8DE0-D12581841549Q34627718-8373BFF0-2FB5-493E-BE44-1359FCB7B042Q34831733-14D4A721-5216-44F9-A135-C8035049094BQ35176859-89618FE4-8109-4547-A181-736A9257C7DDQ35798763-1F6BF108-6915-476B-9E9F-D9524AF1E7C3Q36027236-ECCFCC2C-1D53-4776-83EB-36DC6CAE73A1Q36036867-637FE7A0-C665-41B5-8104-273F069C6D22Q36098627-008069DD-34EF-441A-B5E8-BDFBB93228EFQ36302342-2E7C0B55-9C45-45A0-8554-78C3165CA866Q36944531-AD660FB6-8549-4CE4-9496-1A4E0E313054Q37052785-D26960F8-C24A-4499-B830-8D5E87A54891Q37404608-C5D59976-2343-41D3-966F-1235B2B44FCCQ37420760-AF4EEA1A-77D6-4446-BD46-E290CB09D405Q37525896-AB24DA6A-5C2A-4098-9863-220992BE4A70Q40413523-C97BF1D8-E5CC-4B85-9374-97BF0B87AF62Q40420915-A8DB8FC5-0E66-4E21-AFE3-0297BB8C3EE9Q40792146-7C06F0CA-1481-41DA-9FD6-F78A72F3BB1AQ40959560-0EB3CC68-F84C-4899-ABB9-1CB367D94DBCQ41849121-5D2F389D-3BFC-4165-B930-7F7AE9687FE2Q42624537-26193C62-67F3-440A-9B18-9BD4C237642CQ43796599-377ED8D1-00E5-4D6A-B3D1-AC058FB99EB0Q44850009-E7BB5C00-D1B7-4DA7-8C8D-30AF90B4A992Q45341222-242E4E0D-6D65-48E6-A8E4-AB4B0CAD9220Q45954390-1E6AD9E2-F9AC-4196-8621-62FFFC885445Q46022805-E8CC4BAA-1AF7-474F-AF39-CC2FEDDE1E9BQ47222459-A1817259-89E7-4DCA-BC4D-B5DAF0AE73B8Q47639101-A2171ED1-03FA-4320-ABFB-AE1E2D42A251Q47866482-20DA07FE-4B9B-4657-B2A6-521087717AEEQ48096490-2AF7A523-AF06-46BE-B849-219700A75B90Q48097480-52CAF73D-65FB-4FC1-801E-E3CAC442D150Q48364743-730C3B58-BE82-44B1-BE29-C19DE0FC87C3
P50
name
Ulrike Waje-Andreassen
@ast
Ulrike Waje-Andreassen
@en
Ulrike Waje-Andreassen
@nl
type
label
Ulrike Waje-Andreassen
@ast
Ulrike Waje-Andreassen
@en
Ulrike Waje-Andreassen
@nl
prefLabel
Ulrike Waje-Andreassen
@ast
Ulrike Waje-Andreassen
@en
Ulrike Waje-Andreassen
@nl
P21
P31
P569
1962-01-01T00:00:00Z